These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18080615)

  • 21. Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.
    Iwata H; Sato N; Masuda N; Nakamura S; Yamamoto N; Kuroi K; Kurosumi M; Tsuda H; Akiyama F; Ohashi Y; Toi M
    Jpn J Clin Oncol; 2011 Jul; 41(7):867-75. PubMed ID: 21719750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant therapy with gemcitabine in breast cancer.
    Schneeweiss A; Bastert G; Huober J; Wallwiener D; Hamerla R; Lichter P
    Oncology (Williston Park); 2004 Dec; 18(14 Suppl 12):27-31. PubMed ID: 15685823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bevacizumab added to neoadjuvant chemotherapy for breast cancer.
    Bear HD; Tang G; Rastogi P; Geyer CE; Robidoux A; Atkins JN; Baez-Diaz L; Brufsky AM; Mehta RS; Fehrenbacher L; Young JA; Senecal FM; Gaur R; Margolese RG; Adams PT; Gross HM; Costantino JP; Swain SM; Mamounas EP; Wolmark N
    N Engl J Med; 2012 Jan; 366(4):310-20. PubMed ID: 22276821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Metastatic breast cancer].
    Krankenpfl J; 2003; 41(1-3):38. PubMed ID: 12718266
    [No Abstract]   [Full Text] [Related]  

  • 25. Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial.
    de Gregorio A; Häberle L; Fasching PA; Müller V; Schrader I; Lorenz R; Forstbauer H; Friedl TWP; Bauer E; de Gregorio N; Deniz M; Fink V; Bekes I; Andergassen U; Schneeweiss A; Tesch H; Mahner S; Brucker SY; Blohmer JU; Fehm TN; Heinrich G; Lato K; Beckmann MW; Rack B; Janni W
    Breast Cancer Res; 2020 Oct; 22(1):111. PubMed ID: 33097092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gemcitabine/epirubicin/paclitaxel as neoadjuvant chemotherapy in locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group.
    Hamm JT; Wilson JW; Rastogi P; Lembersky BC; Tseng GC; Song YK; Kim W; Robidoux A; Raymond JM; Kardinal CG; Shalaby IA; Ansari R; Paik S; Geyer CE; Wolmark N;
    Clin Breast Cancer; 2008 Jun; 8(3):257-63. PubMed ID: 18650156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant sequential epirubicin and docetaxel followed by surgery-radiotherapy and post-operative docetaxel or gemcitabine/vinorelbine combination based on primary response: a multimodality approach for locally advanced breast cancer.
    Kountourakis P; Missitzis I; Doufexis D; Zobolas V; Pissakas G; Arnogiannaki N; Maliou S; Sotiropoulou A; Ardavanis A
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):221-8. PubMed ID: 20387073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gemcitabine plus dose-escalated epirubicin in advanced breast cancer: results of a phase I study.
    Lüftner D; Flath B; Akrivakis C; Mergenthaler HG; Ohnmacht U; Arning M; Possinger K
    Invest New Drugs; 1998; 16(2):141-6. PubMed ID: 9848577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study.
    von Minckwitz G; Rezai M; Loibl S; Fasching PA; Huober J; Tesch H; Bauerfeind I; Hilfrich J; Eidtmann H; Gerber B; Hanusch C; Kühn T; du Bois A; Blohmer JU; Thomssen C; Dan Costa S; Jackisch C; Kaufmann M; Mehta K; Untch M
    J Clin Oncol; 2010 Apr; 28(12):2015-23. PubMed ID: 20308671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy in stage II and III breast cancer patients: preliminary results of a phase II and pharmacogenomic study.
    Estévez LG; Sánchez-Rovira P; Dómine M; León A; Calvo I; Jaén A; Casado V; Rubio G; Daz M; Miró C; Lobo F
    Semin Oncol; 2004 Apr; 31(2 Suppl 5):31-6. PubMed ID: 15199530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil– epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy.
    Ohno S; Chow LW; Sato N; Masuda N; Sasano H; Takahashi F; Bando H; Iwata H; Morimoto T; Kamigaki S; Nakayama T; Nakamura S; Kuroi K; Aogi K; Kashiwaba M; Yamashita H; Hisamatsu K; Ito Y; Yamamoto Y; Ueno T; Fakhrejahani E; Yoshida N; Toi M
    Breast Cancer Res Treat; 2013 Nov; 142(1):69-80. PubMed ID: 24122389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant triweekly nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for Stage II/III HER2-negative breast cancer: evaluation of efficacy and safety.
    Shimada H; Ueda S; Saeki T; Shigekawa T; Takeuchi H; Hirokawa E; Sugitani I; Sugiyama M; Takahashi T; Matsuura K; Yamane T; Kuji I; Hasebe T; Osaki A
    Jpn J Clin Oncol; 2015 Jul; 45(7):642-9. PubMed ID: 25989989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gemcitabine combined with epirubicin in the treatment of patients with locally advanced or metastatic breast cancer: a phase II study.
    Hausmaninger H; Morack G; Heinrich B; Wallwiener D; Höffken K; Buksmaui S; Krejcy K; Miller MA; Possinger K
    Am J Clin Oncol; 2004 Aug; 27(4):429-35. PubMed ID: 15289740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluation.
    Wardley AM; Hiller L; Howard HC; Dunn JA; Bowman A; Coleman RE; Fernando IN; Ritchie DM; Earl HM; Poole CJ;
    Br J Cancer; 2008 Aug; 99(4):597-603. PubMed ID: 18665163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer.
    Alvarado-Miranda A; Arrieta O; Gamboa-Vignolle C; Saavedra-Perez D; Morales-Barrera R; Bargallo-Rocha E; Zinser-Sierra J; Perez-Sanchez V; Ramirez-Ugalde T; Lara-Medina F
    Radiat Oncol; 2009 Jul; 4():24. PubMed ID: 19591689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gemcitabine and epirubicin in patients with metastatic breast cancer: a phase I/II study.
    Campone M; Fumoleau P; Viens P; Diéras V; Pujade-Lauraine E; Serin D; Petit T; Espié M; Kayitalire L; Bozec L; Pouillart P
    Breast; 2006 Oct; 15(5):601-9. PubMed ID: 17045160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase 2 study of sequential neoadjuvant chemotherapy with gemcitabine and doxorubicin followed by gemcitabine and cisplatin in patients with large or locally advanced operable breast cancer: results from long-term follow-up.
    Julka PK; Chacko RT; Nag S; Parshad R; Nair A; Koppiker CB; Xue FC; Barraclough H; Dhindsa N; Seth A; Majumdar A; Puri T
    Breast Cancer; 2013 Oct; 20(4):357-62. PubMed ID: 22354450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A population-based study on the patterns of use of different chemotherapy regimens in Swiss patients with early breast cancer.
    Joerger M; Ess S; Dehler S; Savidan A; Bouchardy C; Frick H; Konzelmann I; Thürlimann B
    Swiss Med Wkly; 2012; 142():w13571. PubMed ID: 22495767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclophosphamide, doxorubicin, and gemcitabine combination chemotherapy for treatment of metastatic and locally advanced breast cancer.
    Levin M; Durgam S; Novetsky A
    Cancer Invest; 2002; 20(7-8):872-5. PubMed ID: 12449716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography.
    Rousseau C; Devillers A; Sagan C; Ferrer L; Bridji B; Campion L; Ricaud M; Bourbouloux E; Doutriaux I; Clouet M; Berton-Rigaud D; Bouriel C; Delecroix V; Garin E; Rouquette S; Resche I; Kerbrat P; Chatal JF; Campone M
    J Clin Oncol; 2006 Dec; 24(34):5366-72. PubMed ID: 17088570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.